Treatment of active spondyloarthropathy with infliximab, the chimeric monoclonal antibody to tumour necrosis factor alpha. (Q34560557)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Treatment of active spondyloarthropathy with infliximab, the chimeric monoclonal antibody to tumour necrosis factor alpha. |
scientific article |
Statements
Treatment of active spondyloarthropathy with infliximab, the chimeric monoclonal antibody to tumour necrosis factor alpha (English)
F Van den Bosch
D Baeten
E Kruithof
F De Keyser
H Mielants
1 November 2001
1 reference
1 reference
1 reference
1 reference